Board Meeting27 Oct 2026, 09:00 pm
Piramal Pharma declares Q2 FY27 Unaudited Financial Results
AI Summary
Piramal Pharma Limited announced the approval of its Unaudited Financial Results (Standalone & Consolidated) for the quarter and half-year ended September 30, 2026. The Board of Directors met on October 27, 2026, to review and approve these results, along with the Limited Review Reports from the statutory auditors. The financial results will be published in newspapers as per SEBI regulations and are also available on the company's website. The meeting commenced at 5:30 pm and concluded at 8:30 pm.
Key Highlights
- Board approved Unaudited Financial Results for Q2 FY27.
- Results include both Standalone and Consolidated figures.
- Limited Review Reports from auditors were also approved.
- Financials cover the quarter and half-year ended September 30, 2026.
- Results to be published in newspapers and on the company website.
Price Impact
More from PPLPHARMA